Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
China is the largest consumption region of Sarcopenia Treatment, with market share nearly 30.83%. The second largest market is United States; following China with the market share of 24.48%.
Market Analysis and Insights: Global Sarcopenia Treatments Market
In 2019, the global Sarcopenia Treatments market size was US$ 2516.3 million and it is expected to reach US$ 3459.4 million by the end of 2026, with a CAGR of 4.6% during 2021-2026.
Global Sarcopenia Treatments Scope and Market Size
Sarcopenia Treatments market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sarcopenia Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Sarcopenia Treatments market is segmented into Protein Supplement, Calcium Supplement, Other, etc.
Segment by Application, the Sarcopenia Treatments market is segmented into Online Pharmacies, Retail Pharmacies, etc.
Regional and Country-level Analysis
The Sarcopenia Treatments market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sarcopenia Treatments market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Sarcopenia Treatments Market Share Analysis
Sarcopenia Treatments market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Sarcopenia Treatments business, the date to enter into the Sarcopenia Treatments market, Sarcopenia Treatments product introduction, recent developments, etc.
The major vendors include Abbott Laboratories, Nestlé, Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline, Bayer, H&H, Blackmores, Zhendong Group, etc.

This report focuses on the global Sarcopenia Treatments status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sarcopenia Treatments development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Abbott Laboratories
Nestlé
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
Bayer
H&H
Blackmores
Zhendong Group

Market segment by Type, the product can be split into

Protein Supplement
Calcium Supplement
Other
The proportion of protein supplement in 2018 is about 57%.

Market segment by Application, split into

Online Pharmacies
Retail Pharmacies
The most of sarcopenia treatments is sales through retail pharmacies, and the market share of that is about 66% in 2018.

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Sarcopenia Treatments status, future forecast, growth opportunity, key market and key players.
To present the Sarcopenia Treatments development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Sarcopenia Treatments are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.